Compare Summit Therapeutics Inc (SMMT) vs TeraWulf Inc (WULF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Summit Therapeutics Inc vs TeraWulf Inc — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while TeraWulf Inc trades at $20.04 (market cap $9.35B). The key difference: Summit Therapeutics Inc and TeraWulf Inc are close in size by market cap, and TeraWulf Inc is trading nearer its 52-week high, Summit Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| SMMT | WULF | |
|---|---|---|
Market Cap | $10.48B | $9.35B |
Sector | Health | Technology |
52-Week High | $29.32 | $28.98 |
52-Week Low | $13.05 | $4.76 |
Enterprise Value | $9.90B | $12.03B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →About TeraWulf Inc
TeraWulf develops, owns, and operates fully integrated digital infrastructure powered by predominantly zero-carbon energy. It utilizes a hybrid business model that combines industrial-scale Bitcoin mining with high-performance computing (HPC) and AI hosting, leveraging sustainable power sources like nuclear and hydroelectric to deliver low-cost, energy-efficient data center solutions.
Read more on WULF →
